Sex differences in skeletal muscle regeneration are controversial; comparisons of regenerative events between sexes have not been rigorously defined in severe injury models. We comprehensively quantified inflammation and muscle regeneration between sexes and manipulated sex-specific hormones to determine effects on regeneration.
INTRODUCTION
Skeletal muscle regeneration is an important component of limb salvage following severe injury induced by traumatic and/or ischemic extremity injury. Multiple cellular and molecular components involved in skeletal muscle regeneration have been studied and controversies exist regarding effects of sex in muscle injury, inflammation and regeneration (28, 41, 62, 63) . A better understanding of the role that sex plays in muscle regeneration could lead to sex-specific treatment strategies for limb salvage.
The male and female response to injury varies by organ system and mechanism of injury. For example, female mice exhibit less ischemia and reperfusion injury than males after hepatic surgery (25) ; however, alcoholic liver injury is more severe in female rats (35) . Also, sex-specific protection leads to decreased acute lung injury in female mice (48) , but female rats exhibit increased pulmonary fibrosis after injury (23) .
Although not entirely understood, these differences have been primarily attributed to sex-specific hormones, specifically estrogen.
Estrogen positively affects immune responses by acting as a modulator of proinflammatory responses (9) . Normalization and maintenance of the immune response has been attributed to estrogen leading to decreased organ injury and sepsis in females after trauma (13, 16, 30, 69) . Estrogen also is an antioxidant, thereby exerting a protective influence (7, 36, 40, 49, 58) .
Estrogen and sex influences on post-exercise injury has been debated; with rodent models suggesting decreased injury and inflammation in females, however, similar studies in humans are variable or show no sex differences (28, 41, 62, 63) .
Exercise-induced muscle injury is a common model used in rodents and humans. In skeletal muscle, sex-specific differences in injury have generally revealed decreased injury in female rodents (1, 8, 18, 20, 60) . Most of these studies have used enzyme release as a marker of injury, most commonly creatine kinase, with decreased levels released after injury in females (2, 3, 10) . Examination of the morphological changes in skeletal muscle after injury yields mixed results of either similar (4, 53) or decreased muscle damage in females (65) . Furthermore, neutrophil recruitment was attenuated in female compared to male rats after exercise-induced injury and estrogen supplementation in males decreased neutrophil recruitment to similar levels observed in females (59) .
Sex influences on muscle regeneration would also appear to favor females in regards to satellite cells. Satellite cells, or myogenic progenitor cells, are the primary progenitor cells responsible for successful skeletal muscle regeneration (39, 45, 70) ; stimulation by estrogen leads to increased activation and proliferation (17, 18, 61) .
Additionally, muscle-derived stem cells from females, compared to males, were more efficient at regenerating injured skeletal muscle in both sexes (15) .
The current study used cardiotoxin (CTX) injury, an established model of extensive muscle injury and regeneration (26, 34, 37, 54) . CTX contains lytic factors that degrade the muscle plasma membrane (26) resulting in muscle necrosis followed by an inflammatory response with angiogenesis and skeletal muscle regeneration (34, 37, 54) . The larger extent of injury obtainable using CTX, compared to the mild to moderate injury with exercise-induced muscle injury, maybe more consistent with clinically treated traumatic injuries.
Given the reported female advantages in injury and regeneration in rodents in exercise-induced muscle injury (19, 28, 41, 62, 63) , we hypothesized that females mice would exhibit less injury and larger regenerated CSA at earlier time points after extensive injury compared to male mice. The purpose of this study was to determine inflammatory cell recruitment, injury, necrosis, inflammatory chemokines and muscle regeneration in intact male and female mice in a more extensive model of muscle injury.
Furthermore, we aimed to determine the influence of sex-specific hormones on muscle regeneration.
MATERIALS AND METHODS
Experimental animals. C57Bl/6J mice were purchased from Jackson Labs. Mouse cardiotoxin (CTX) model. Myonecrosis was induced by the intramuscular injection of CTX (Calbiochem, San Diego, CA) as previously described (34, 37, 54) . In brief, two 50-µL CTX [2.5 µM in normal saline (NS)] injections were delivered uniformly into the muscles of the right hind limb anterior compartment.
Similarly, the right hind limb posterior compartment received four 50-µL CTX injections.
The left hind limb was injected with identical volumes of NS. Baseline mice did not receive intramuscular injections and were used as controls.
Mouse castration and ovariectomy (OVX) model. Twelve week old male mice underwent castration. The castrations were performed by making a small incision on the scrotum in the midline and the testicles were elevated bilaterally, suture ligated, and transected. The scrotal skin was closed and the mouse recovered. Twelve week old female mice underwent bilateral OVX. Two small dorsal incisions were made just below the inferior aspect of the ribcage bilaterally, the peritoneum was incised, the ovaries were identified, removed, the ovarian vessels were suture ligated, and the skin incisions were closed. At sacrifice, the uterus and plasma were collected and used to determine adequacy of OVX; plasma samples were stored at -80 o C. Following castration and OVX, acetaminophen and codeine were administered via drinking water and mice were monitored for ten days to ensure complete recovery. The mice were allowed to recover for at least 4 weeks before using the animals at 4-6 months of age for baseline or CTX injection studies. Tissue lysates were thawed on ice for 15 min and immediately centrifuged (3,300-16,100 x g, 4°C, 10 min). Protein was determined by the Pierce BCA™ protein assay (Pierce Biotechnology, Inc., Rockford, IL) using a microtiter plate format; bovine serum albumin (BSA) from ICN Biomedicals Inc. (Costa Mesa, CA) in lysate buffer was used as the standard (34, 37, 46) . Absorption in microtiter plates was monitored in a SpectraMax Plus plate reader (Molecular Devices, Sunnyvale, CA) and results analyzed with SOFTmax PRO software (Molecular Devices).
17-β Estradiol
MCP-1 and MCP-5 levels in tissue lysates were assessed by enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN), according to manufacturer's protocol with slight modifications as previously described (34, 46) . Standards and unknowns were diluted in lysate buffer and results were expressed as pg/mg protein.
Measurement of plasma E2 and P4 levels. Levels of E2 and P4 in mouse plasma were assessed in ELISA according to the manufacturer's protocol (Cayman Chemical Co, Ann Arbor, MI). The lower limit of sensitivity for these assays was 32.8 pg/ml and 31.25 pg/ml for E2 and P4, respectively.
Tissue monocyte/macrophage and neutrophil quantification. Cells from muscle were isolated as previously described (54) . Briefly, all muscles from the anterior and posterior compartments were removed at 3 or 7 days after injury. The total cell count was manually determined on a hemocytometer and divided by the weight of the tissue. The percentage of cells from each population was determined by flow cytometry (described below) and the absolute number of each cell population was calculated and expressed as cells/g tissue.
Monocytes/macrophages and neutrophils were analyzed by a modified procedure for muscle associated cells as previously described (32, 54) . Neutrophils were defined as CD11b+/Gr-1+ and monocytes/macrophages were defined as CD11b+/Gr-1-cells. The fluorescently-conjugated monoclonal antibodies (from BD Biosciences, San Jose, CA) were as follows: APC Gr-1 and PE CD11b, as well as the corresponding isotype control antibodies. Isotype controls were used to titrate each antibody to minimize nonspecfic binding.
Histology and histomorphometry.
Myofiber cross-sectional area (CSA) and percent fat in tibialis anterior (TA) muscle were analyzed as previously described in detail (34, 37, 54) . In brief, mice were sacrificed at baseline or at various time points following CTX and NS injections. The right and left TA muscles were removed, fixed in 10% neutral buffered formalin, and embedded in paraffin prior to sectioning and staining with hematoxylin and eosin (H&E) by routine procedures. The average CSA (µm 2 ) of myofibers in specimen was determined after outlining individual myofibers in representative, digitized images of a given TA muscle. Only regenerated fibers with centrally located nuclei (11) were measured in the post-CTX specimen to minimize the effect of differences in injury; whereas, mature myofibers with peripherally located nuclei were measured in baseline specimen. Fat area (%) in a given image was calculated after manual outline of intermuscular adipocyte area and division by the total area of the image. Data for male mice was previously published (34) .
The area of muscle injury and residual necrosis in the TA muscle of individual animals obtained at days 5 & 7 post-CTX was analyzed as previously described (34) .
Hematoxylin and eosin (H&E) stained cross-sections were measured after digital scanning of microscope slides using a model CS ScanScope system (Aperio Technologies, Inc, Vista, CA, USA). The digitally captured slide was analyzed via ImageScope software (version v10.0.36.1805; Aperio Technologies, Inc) to measure the total area of the TA, area of TA injury, and area of residual TA necrosis. The entire area of injury for a given TA muscle in cross-section was defined as the area of regenerated muscle cells with centrally-located nuclei in combination with the area of residual necrotic myofibers. Percent necrosis was calculated as the area of necrosis relative to the entire area of injury. Percent injury was calculated as the entire area of injury relative to the entire cross-sectional area of the TA. Necrosis and injury data for male mice at the day 7 time point were previously published (34) .
Oil red O staining of unfixed frozen sections of tibialis anterior muscle was performed using a kit from Poly Scientific (Bay Shore, NY) as previously described (14) .
Determination of percent total body fat. Body fat (%) in baseline mice only was determined in anesthetized animals (intraperitoneal pentobarbital; 60 mg/kg, Abbott Laboratories, Chicago, IL) using a PIXImus Mouse Densitometer (General Electric Corp., Waukesha, WI). Data for male mice was previously published (37, 54 (<15.625pg/ml) and MCP-1 (<78 pg/ml), a value of the lowest detectable level/ 2 pg/ml was assigned to these samples (27) and this value was corrected for the protein in each specimen (34) . Percent injury and percent necrosis in intact male, intact female, and OVX female were analyzed using ANOVA with Tukey correction. Percent total body fat was analyzed by an unpaired Student's t test. SAS Version 9.2 for Windows (SAS Institute, Cary, North Carolina) was used for statistical analyses and all statistical testing was two-sided with an experiment wide significance level of 5%. Data were presented as the mean + standard error (SE).
RESULTS
Histologic evaluation of skeletal muscle injury and regeneration. Acute myonecrosis, edema, and inflammatory cell infiltration developed in both male and female mice following CTX injection. At day 1 post-injury, the predominant inflammatory cell was the polymorphonuclear neutrophilic leukocyte, whereas, by day 3 in both groups, the principal cell was mononuclear. Small regenerated myofibers with centrallylocated nuclei were prevalent within 5 days post-injury in both male and female mice Sex-dependent histomorphometric differences in muscle regeneration.
While the wet weight of the anterior compartment muscles was increased in males compared to females, similar weights were obtained between the CTX and NSinjected anterior compartments. Given the known differences in body weight between male and female mice, it is not surprising that the baseline (non-injured) myofiber CSA of male mice was larger (p < 0.001) than that of female mice (Fig. 4A) . In contrast, the CSA of regenerated myofibers was similar between male and female mice through 21 days post-injury. For both sexes, regenerated myofibers progressively increased in size with time following injury and, at days 7 and 14, were smaller (p ≤ 0.001) than baseline myofibers (Fig. 4A) . At 21 days post-CTX, regenerated myofibers in male mice remained smaller (p = 0.01) than baseline muscle, whereas, for female mice, regenerated myofibers were comparable in size to mature, baseline myofibers.
The extent of skeletal muscle injury within the TA muscle was extensive; >80% of the entire muscle, in both male and female mice ( Table 1) . At day 5, muscle injury was greater (p = 0.02) in females compared to males. In part, this may reflect the fact that necrotic myofibers were virtually eliminated and replaced by small regenerated myofibers in female mice. In contrast, necrotic myofibers were persistent and increased (p ≤ 0.05) in the injured muscle of male compared to female mice at both days 5 and 7
( Table 1) .
Intermuscular fat was not detectable in baseline (non-injured) TA muscle of male and female mice, and the percentage of total body fat was similar in baseline mice between males (15.7% ± 0.57) and females (16.8% ± 0.52). Following injury, intermuscular adipocytes were increased (p ≤ 0.008) within the regenerated muscle in both sexes through day 21 (Fig 4B) . Somewhat surprising given the effectiveness of removal of necrotic myofibers and the robust growth of regenerated fibers in female mice, the extent of adipocyte accumulation within regenerated muscle was greater in female compared to male mice at day 14 post-CTX (p = 0.03).
Effect of castration or OVX on regenerated myofiber size and intermuscular
fat accumulation. The size of mature, baseline (non-injured) myofibers was similar following castration or OVX compared to intact mice; however, castrated males, similar to intact males, did exhibit larger (p < 0.05) baseline CSA compared to both intact and OVX females (Fig. 5A ) and all groups after injury were smaller than baseline (p < 0.001). At day 14 post-injury, regenerated myofiber size in castrated or OVX mice was comparable to that of intact male or female mice, respectively (Fig. 5A) . In addition, percent injury (86 + 4 vs 94 + 1) and necrosis (0.03 + 0.02 vs 0.02 + 0.01) was similar between intact and OVX females at day 7 after CTX injury.
In contrast to regenerated myofiber size, the intermuscular accumulation of fat within regenerated muscle was significantly changed following castration (Fig. 5B) .
Thus, at 14 days post-injury, the percentage of intermuscular fat within regenerated muscle was increased (p = 0.01) following castration compared to intact males and was decreased, although not significantly, following OVX compared to intact females (Fig. 5B ). These observations suggested the involvement of sex hormones in the expansion of adipocytes within regenerating muscle.
Effect of hormone replacement on regenerated myofiber size and intermuscular fat accumulation in injured skeletal muscle of OVX mice. Given the differences observed in intermuscular fat accumulation in mice, the effects of hormone replacement via implantable pellets was examined. OVX mice received implantable pellets designed to release either low doses or high doses of 17-β estradiol (E2) or progesterone (P4).
Uterine weights are an accurate indicator of the completeness of OVX and hormone replacement (6, 67) . Uterine weights at day 14 post-injury were decreased (p < 0.001) following OVX compared to intact female mice (Fig. 6A) . After hormone replacement of OVX mice, uterine weights were increased (p < 0.001) compared to intact female mice with both the low doses and high doses of E2. With P4 replacement following OVX, uterine weights were decreased (p < 0.001) in the low dose group compared to intact animals (Fig. 6A) . Compared to the OVX with placebo group, the high dose P4 and both E2 groups demonstrated increased (p < 0.003) uterine weights.
E2 and P4 plasma levels were also determined using ELISA. E2 levels were below the level of detection (32.8 pg/ml) except for the high dose E2 replacement group, 741 ± 66 pg/ml. The P4 levels were detectable for all replacement groups (Fig. 6B) . At baseline, uninjured, intact female mice had higher levels than the baseline, uninjured OVX mice and 14-day placebo OVX mice. This increased level correlates with the cyclicity of the estrous female. The E2 replaced mice had dose-dependent decreased levels of P4.
High dose P4 replacement mice had higher levels (p < 0.001) than all other groups.
Both the low dose and high dose P4 replacement mice demonstrated significantly increased levels of P4 (p ≤ 0.008) compared to baseline, uninjured OVX mice.
Regenerated myofiber size was comparable among all OVX and hormone treated groups with the exception of the high dose E2. In the latter, regenerated myofiber size was decreased (p < 0.001) compared to all the other groups (Fig. 6C) .
Similarly, the intermuscular accumulation of fat within regenerated muscle was lower, but not significantly different between the P4 groups and intact females. However, both doses of E2 replacement resulted in decreased (p < 0.03) percent fat compared to intact female mice (Fig. 6D) .
DISCUSSION
The present study examined the influence of sex and sex-specific hormones on Female mice exhibited comparable (day 7) or increased (day 5) injury after similar exposure to hind limb injections of CTX compared to male mice. This is contrary to reports that the female sex provides protection against injury which has been reported in multiple organ systems such as lung (9, 48) , heart (40), brain/nervous system (49), skeletal system (40) and skeletal muscle after exercised-induced muscle damage (17, 57, 62, 63) . These studies attribute the differences in extent of injury to sex with potential mediation by estrogen. One possible explanation for the mildly increased level of injury observed in our lab is the variability of the CTX injection. However, our model typically achieves high levels of injury with each injection. More likely is that female sex does not confer decreased injury after extensive muscle injury. Skeletal muscle injury after exercise has been the primary model used with the majority of studies showing decreased injury in females (1, 8, 18, 20, 60) . Most of these exerciseinduced injury studies have used enzyme release as a marker of injury, most commonly creatine kinase, with decreased levels released after injury in females (2, 3, 10) .
Enzyme levels, however, may be inadequate markers of muscle injury inaccurately reflecting the degree of histological damage (31, 65) . Furthermore, an increase in creatine kinase in males compared to females may not be a reflection of increased injury, but rather, the increased muscle mass and body weight present in male mice. In addition, the membrane stabilizing effect of estrogen that may protect muscle in exercise-induced injury model (1) (2) (3) 8) could be overcome by the more extensive injury induced by CTX.
Female mice were more efficient at removing necrotic muscle fibers after injury but at the expense of increased fat deposition. This efficiency occurred despite similar levels of inflammatory cells and pro-inflammatory chemokines (MCP-1 and MCP-3).
Neutrophil accumulation was similar between males and females after CTX injury (Fig   2A) . However, neutrophil accumulation, measured using myeloperoxidase levels after exercise-induced muscle damage, was decreased in female compared to male rats (59) . Differences in time points, muscles tested, mechanism and extent of injury may account for these variances. Monocyte/macrophage recruitment was also similar between male and female mice (Fig 2B) , confirming a previous study of muscle injury that demonstrated similar numbers of CD11b+ cells between the sexes, however, differences in macrophage subsets were noted (50) . Macrophage subset studies were not performed herein, but could potentially account for the increased efficiency in removing necrotic fibers in females versus males despite similar overall numbers of inflammatory cells. While inflammatory cell recruitment and tissue chemokines were not measured after OVX, removal of necrotic fibers and CSA was similar in OVX and intact female mice.
Surprisingly, the CSA of both sexes was remarkably similar throughout regeneration; castration and OVX did not influence regenerated fiber CSA. At baseline before injury, male mice have a known increase in CSA and muscle mass compared to female mice (24, 44) . Interestingly, after injury, the baseline difference was not reflected in the similar CSA at days 7-14. By day 21, female CSA was similar to baseline while male mice were still decreased. Muscle-derived stem cells have been used to regenerate muscle in dystrophic mice (42) . Female muscle-derived stem cells more efficiently regenerated skeletal muscle in both male and female mice (15) . Furthermore, estrogen increases activation and proliferation of satellite cells (17, 18, 61) . While satellite cell activation and muscle function were not measured in the current study, the regeneration advantage of estrogen was not observed in the female mice as measured using CSA; in contrast, increased intermuscular fat was present in females, suggesting impaired/altered regeneration.
Uninjured, mature male and female mice had similar percent total body fat in our study and a previous study (47) . This finding is different than human males and females with ranges of 10-15% and 20-25% respectively (43) . In spite of similar percent total body fat at baseline, female mice had increased intermuscular fat accumulation after injury. The finding of increased fat accumulation occurring in regenerating skeletal muscle has been reported by our group (14, 34, 37) and others (66, 68) but not specifically related to sex. Interestingly, increased fat accumulation in injured muscle was associated with decreased monocyte/macrophage recruitment observed in MCP-1-/-and CC Chemokine Receptor 2-/-mice (34) . Fat deposition in skeletal muscle has been reported in the elderly (21) and in muscle wasting diseases such as muscular dystrophy (29) and may represent altered/impaired muscle regeneration.
Studies that show a sex-specific difference in response to injury primarily attribute this result to sex specific-hormones, in particular testosterone and estrogen, (9, 30, 38, 40, 48) . We performed castrations and OVX to alter the hormone levels and examined the resultant changes in injury and regeneration. Castration resulted in similar CSA during regeneration and OVX had similar injury and CSA compared to intact mice despite these procedures removing a significant portion of the hormonal influence.
Interestingly, intermuscular fat accumulation did increase in castrated males and decrease in OVX females. Age-related decreases in testosterone resulted in an increase in total body fat (12, 64) but were not specific to skeletal muscle deposition.
Our findings suggest a hormonal influence on the amount of intermuscular fat after injury.
P4 replacement in OVX mice does not appear to confer any protective benefit after extensive muscle injury. The levels of P4 measured in the E2 replacement mice correlated with the negative feedback cycle of the mouse. E2 and P4 both exert a respective negative feedback control on leutinizing hormone. Leutinizing hormone increases the level of E2 and P4; however, increased levels of either hormone negatively control the level of leutinizing hormone resulting in decreased levels of the other hormone (22) potentially leading to the decreased levels of P4 measured herein.
However, the OVX with hormone replacement mice revealed a dose dependent effect of E2 replacement. Mice receiving both doses of E2 had less intermuscular fat compared to intact females while only mice that received high dose high dose E2 had significantly smaller CSA compared to intact and all the other OVX groups. A limitation of the current study is the inability to determine if the effects of estrogen replacement after OVX were primary or secondary. OVX leads to insulin resistance in skeletal muscle and an increase in adipose tissue and E2 administration resulted in a decrease in visceral but not subcutaneous adiposity (5) . Further studies are needed to determine the mechanism of these effects.
Studies demonstrating a protective effect of estrogen all used low dose replacement (25, 30, 40) . The tantalizing possibility of using high dose estrogen to improve muscle regeneration was not supported by our study. A potential limitation to our study is the reported variance in E2 levels delivered via the pellet method resulting in uneven and unpredictable plasma E2 concentrations (52) . Another studied reported opposing effects on neural tissue after stroke relative to the method of administration of E2 (51) . Nevertheless, given these findings, administration of low dose E2 in postmenopausal women may have a positive effect on regeneration after injury and is a potential future area of exploration. However, studies in neural and vascular tissue have shown that hormone replacement therapy provides the most benefit when initiated in close proximity to menopause (33, 55, 56) ; the effect of timing of hormone replacement therapy for skeletal muscle will require further research.
Perspectives and significance
In conclusion, there are sex-related differences in recovery from skeletal muscle injury; female mice demonstrated similar injury and regenerated myofiber size compared to males while high dose E2 resulted in decreased regenerated CSA.
Adipocyte accumulation in regenerating muscle was influenced by sex-specific hormones; females healed with increased intermuscular fat compared to males and removal of male hormones resulted in increased intermuscular fat. While high dose E2 decreased intermuscular fat, CSA was also decreased in OVX mice. Given the considerable literature on exercise-induced muscle injury, our study may assist in defining sex-specific differences present after more extensive injury seen in trauma patients. Injury recovery is different between males and females and sex-specific hormones contribute to these differences, suggesting that sex-specific treatments could be beneficial after injury.
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